Imunon (NASDAQ:IMNN) PT Raised to $14.00 at HC Wainwright

Imunon (NASDAQ:IMNN – Free Report) had its target price increased by HC Wainwright from $12.00 to $14.00 in a report issued on Monday, Benzinga reports. The firm currently has a buy rating on the stock. HC Wainwright also issued estimates for Imunon’s Q3 2024 earnings at ($0.40) EPS, Q4 2024 earnings at ($0.40) EPS, FY2024 […]

Leave a Reply

Your email address will not be published.

Previous post Pulmatrix (NASDAQ:PULM) Now Covered by StockNews.com
Next post Needham & Company LLC Reaffirms “Buy” Rating for Coinbase Global (NASDAQ:COIN)